MedPath

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
Registration Number
NCT00663286
Lead Sponsor
Dow Pharmaceutical Sciences
Brief Summary

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1399
Inclusion Criteria
  • Presence of inflammatory and non-inflammatory lesions
Exclusion Criteria
  • Dermatological conditions of the face other than acne that could interfere with clinical evaluations
  • Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1IDP-110-
4Vehicle-
3Benzoyl peroxide-
2Clindamycin-
Primary Outcome Measures
NameTimeMethod
Change from baseline in number of lesions12 weeks
Secondary Outcome Measures
NameTimeMethod
Change from baseline in global severity12 weeks

Trial Locations

Locations (32)

Central Sooner Research

🇺🇸

Norman, Oklahoma, United States

Derm Center of Augusta

🇺🇸

Augusta, Georgia, United States

Webster Dermatology, PA

🇺🇸

Hockessin, Delaware, United States

Michigan Center for Research Corp.

🇺🇸

Clinton Township, Michigan, United States

Office of Fran E. Cook-Bolden, MD

🇺🇸

New York, New York, United States

Skin Care Research, Inc.

🇺🇸

Boca Raton, Florida, United States

Milton S. Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

Burke Pharmaceutical Research

🇺🇸

Hot Springs, Arkansas, United States

The Savin Center, PC

🇺🇸

New Haven, Connecticut, United States

DuPage Medical Group

🇺🇸

Naperville, Illinois, United States

Dermatology Research

🇺🇸

Pinellas Park, Florida, United States

Dermatology Specialists Research

🇺🇸

Louisville, Kentucky, United States

Advanced Dermatology and Cosmetic Surgery

🇺🇸

Ormond Beach, Florida, United States

Hudson Dermatology

🇺🇸

Evansville, Indiana, United States

Dermatology Associates of Rochester

🇺🇸

Rochester, New York, United States

North Florida Dermatology Associates, PA

🇺🇸

Jacksonville, Florida, United States

MedaPhase Inc.

🇺🇸

Newnan, Georgia, United States

South Bend Clinic

🇺🇸

South Bend, Indiana, United States

J & S Studies, Inc.

🇺🇸

Bryan, Texas, United States

Dallas Associated Dermatologists

🇺🇸

Dallas, Texas, United States

Madison Skin & Research, Inc.

🇺🇸

Madison, Wisconsin, United States

DermResearch, Inc.

🇺🇸

Austin, Texas, United States

Education & Research Foundation

🇺🇸

Lynchburg, Virginia, United States

Virginia Clinical Research, Inc

🇺🇸

Norfolk, Virginia, United States

Helendale Dermatology and Medical Spa

🇺🇸

Rochester, New York, United States

SUNY Downstate Medical Center

🇺🇸

Brooklyn, New York, United States

Atlantic Dermatologic Associates, LLP

🇺🇸

Brooklyn, New York, United States

Florida Dermatology Institute

🇺🇸

West Palm Beach, Florida, United States

DermResearch Center of New York

🇺🇸

Stony Brook, New York, United States

Thomas J. Stephens & Associates

🇺🇸

Carrollton, Texas, United States

Gwinnett Clinical Research Center, Inc.

🇺🇸

Snellville, Georgia, United States

Minnesota Clinical Study Center

🇺🇸

Fridley, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath